CuriRx/CuriOralRx is a pioneering biotech company transforming the global landscape of peptide and protein therapeutics. With a specialized focus on developing advanced oral delivery systems for biologics, CuriOralRx addresses the significant challenge of oral bioavailability for these molecules, creating accessible alternatives to injectable therapies. This patient-centered approach enhances treatment convenience and compliance, supporting CuriOralRx's goal to revolutionize healthcare with oral solutions that meet evolving industry needs. CuriOralRx’s patented delivery platform is engineered to replace injections with convenient oral formulations for peptide and protein-based therapeutics. This platform leverages advanced pH-sensitive polymers and encapsulation techniques to protect sensitive molecules, enabling them to withstand the gastrointestinal environment and achieve precise therapeutic effects.